Abstract:Background: The clinical and morphological spectrum of myelodysplastic syndromes (MDS) during childhood has not yet been completely documented. We herein present the clinical features and morphological data from peripheral blood (PB), bone marrow aspirates (BMA) and bone marrow biopsies (BMB) of a series of paediatric MDS patients, with particular emphasis on their specific morphological characteristics and their diverse underlying genetic background. Patients and methods: Thirty-four patients with MDS (median age 8.45 y) were consecutively diagnosed and treated during a period of 15 y (1988-2002). Diagnosis was based on clinical manifestations, morphology of PB, BMA and BMB, and cytogenetic analysis of BM cells. Clonogenic methylcellulose cell cultures were performed in 23/34 patients. Patients were categorized into group A [26 primary/de novo MDS, i.e. refractory anaemia (RA) 18, RA with excess of blasts (RAEB) 2, RAEB in transformation (RAEB-t) 6] and group B (8 secondary MDS, i.e. RA 4, RAEB 1, RAEB-t 3). Treatment options varied according to protocols active during the period of the study and the availability of a suitable BM donor. Survival probabilities were estimated using the Kaplan-Meier method. Results: Dysplastic features of the erythroid, myeloid and megakaryocytic lineage were detected at BMA in 85%, 50% and 90% of the patients, respectively, while decreased cellularity was found at BMB in 21/34 patients (60%). RA patients of group A presented at BMB significant hypocellularity (14/18) as a prominent finding due to decrease of the myeloid (13/18 patients) and/or the megakaryocytic (14/18 patients) lineage. Hypocellularity in RA was accompanied by dysplasia of the erythroid (17/18 patients) and megakaryocytic (16/18 patients) lineage, the presence of abnormal localization of immature precursors (ALIP, 8/18 patients), fibrosis (5/18) and stromal changes (11/18). Chromosomal aberrations were revealed in 17/34 patients, of which monosomy 7 was present in seven. Cell cultures demonstrated abnormal myeloid and/or erythroid in vitro clonal growth pattern in all the examined patients. An associated disorder or inherited disease, was identified in 14/26 patients (54%) with primary MDS. Cumulative survival of group A patients was 44.2% (RA 66.6%, RAEB/RAEBt 14.6%; p = 0.001), and of the whole group 42.4%, at 14 y. Conclusions: Hypocellularity of significant degree is a constant and prominent feature among paediatric MDS, especially those with RA. A large variety of associated disorders underlies the clinical appearance of paediatric MDS, reflecting their marked heterogeneity. RA represents the prominent subtype during childhood (69% in this study), and it appears to have the best prognosis, while prognosis of RAEB/RAEBt remains extremely poor.

[Hematological study in 27 patients with myelodysplastic syndrome (MDS)]

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

Analysis of the Karyotype Abnormalities and Its Prognostic in 298 Patients with Myelodysplastic Syndrome

Cytogenetic Abnormalities Predict Disease Progression in Primary Myelodysplastic Syndrome: A Multicentric Study in 508 Chinese Patients.

Laboratory Study and Clinical Features of Hypoplastic Myelodysplastic Syndrome

Clinical Analysis of Myelodysplastic Syndrome

CLINICAL ANALYSIS OF 112 CASES OF MYELODYSPLASTIC SYNDROME

[Analysis on Laboratory and Clinical Characteristics in 65 Cases of Myelodysplastic Syndrome].

Clinical analysis for thirty patients with myelodysplastic syndromes

Clinical analysis of 239 cases of myelodysplastic syndrome

Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases

Cytogenetic study and its clinical value in childhood myelodysplastic syndrome

Myelodysplastic Syndrome:A Clinical Study of 99 Cases.

Myelodysplastic syndromes:a clinical analysis of 50 cases

Analysis on Characteristics of Dysplasia in 345 Patients with Myelodysplastic Syndrome

Clinical and Cytogenetic Features of 508 Chinese Patients with Myelodysplastic Syndrome and Comparison with Those in Western Countries

Clinical and Biological Characteristics of Acute Myeloid Leukemia with 20-29% Blasts: a Retrospective Single-Center Study

Study on the Membrane Hemopoietic Cytokine Receptor Expression on Cd34+Bone Marrow Cells of the Patients with Myelodysplastic Syndromes

Erythroleukemia——A Subtype of Myelodysplastic Syndrome?

[Prospective Clinical Study of Diagnosis and Classification for 282 Cases with Primary Myelodysplastic Syndrome].

[Evaluation of the Subsets of Lymphocytes and Their Activated Status in Patients with Myelodysplastic Syndrome].